In some of his first public remarks since getting booed on stage last month over Alzheimer’s drug remarks, Regeneron’s George Yancopoulos acknowledged in an interview he could’ve handled things differently.
STAT+: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill
The Biden administration will fine drugmakers that hiked prices faster than the inflation rate on 27 medicines administered in physician offices. […]
SAN FRANCISCO — In some of his first extended comments since taking over as Biogen’s CEO, Chris Viehbacher described the commercial launches this year of an Alzheimer’s treatment and a… […]
“People are thinking of ChatGPT as like a box. The progress in the field has not been this box,” one expert said at #STATBreakthrough. It’s all the technology inside it. […]